In Alzheimer’s disease (AD), iTBS has been especially beneficial, as it reduces oxidative stress, lowers amyloid-beta and amyloid precursor protein levels, and decreases reactive astrogliosis, a contributor to neuroinflammation. The gene discussed is APP; the disease is Alzheimer disease.